Purchase Order 75N93020P01308

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Pacific Biosciences of California, Inc. for $384,376 on September 1, 2017 for the Sequel System, with final completion by November 17, 2017. Work is performed in Menlo Park, California. The order is firm fixed-price with no small business set-aside.</p>

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $74,878 purchase order to Pacific Biosciences of California, Inc. for biological reagents and buffers to support the Vaccine Research Center's work. As a prime contractor, Pacific Biosciences will provide the requested products for use at its West Menlo Park, California division. The firm fixed price order runs from June 23, 2023 through July 31, 2023 to...

Pacific Biosciences of California, Inc. was awarded a $119,127 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. This multiple delivery order contract, set aside for total small businesses, will provide PacBio kits and reagents to support genomic research initiatives through September 2021. The original solicitation requested brand name only PacBio reagents to fulfill sequencing...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Pacific Biosciences of California, Inc. for $480,000 on September 4, 2019, with a firm fixed price for the AMBIS 1967094 Sequel II System. Work is performed in Menlo Park, California. The order is for a next-generation sequencing instrument system and associated consumables. The contract completion date is January 8, 2020.</p>

This federal contract award is for the provision of Pacific Biosciences' proprietary reagent kits to support genomic research initiatives at the National Institute of Allergy and Infectious Diseases, which is part of the Department of Health and Human Services. The $11,864.64 firm fixed price purchase order has a completion date of July 3, 2024 and was awarded on April 4, 2024 to Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment, reagents, and services...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Pacific Biosciences of California, Inc. on November 22, 2019, with a ceiling value of $11,520.00 for comprehensive PacBio Sequel service contract support. Work is performed at Bethesda, Maryland. The order covers all parts, labor, and consumables required for repair and recommended preventative maintenance of the installed system, with priority service included. Performance is scheduled to conclude February 14,...

The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Pacific Biosciences of California, Inc. to procure specialized reagents for the PacBio Sequel sequencing platform. The $101,845.19 firm fixed-price contract provides the NIAID's Virus Persistence and Dynamics Section with the necessary reagents, such as sequencing kits, binding kits, and consumables, to conduct genomic research on...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $708,000 firm fixed price purchase order to Pacific Biosciences of California, Inc. to deliver one Revio sequencing system. The system includes the sequencing instrument, primary analysis compute, instrument training, and a 12-month warranty. This acquisition fulfills the original solicitation seeking offers for a high-throughput long-read sequencing system...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Pacific Biosciences of California, Inc. for $104,800.00 to provide a SHORT-READ NEXT GENERATION SEQUENCING PLATFORM (ONSO SYSTEM). The contract does not have a set-aside designation and is for the delivery of Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and related services. This award is part of a larger $13.5 million single-award...

<p>The National Human Genome Research Institute awarded a purchase order to Pacific Biosciences of California, Inc. for reagents and kits valued at $24,856.00 on March 18, 2019, with completion by April 30, 2019. Work is performed in Menlo Park, California. The order is firm fixed price with no small business set-aside.</p>